Nonalcoholic fatty liver disease, Nonalcoholic steatohepatitis, Primary sclerosing cholangitis
Conditions
Interventions
None listed
Sponsors
CCDRD Cooperative Clinical Drug Research and Development AG, Galmed Research And Development Ltd.
Eligibility
Sex/Gender
All
Age
18 Years to 64 Years
Countries
Bulgaria
Outcome results
None listed